Page 2 - பயன்பாடு ஒப்புதல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பயன்பாடு ஒப்புதல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பயன்பாடு ஒப்புதல் Today - Breaking & Trending Today

Balloon Juice | COVID-19 Coronavirus Updates: Thursday/Friday, Feb. 4-5


6 new domestic confirmed,
Hebei Province:
Hebei Provincial Health Commission did not report any new domestic positive cases. 50 domestic confirmed case recovered & 12 domestic asymptomatic cases were released from isolation. There are currently 192 domestic confirmed cases (1 serious, 155 moderate and 36 mild) & 10 domestic asymptomatic cases in the province:
Xingtai did not report any new domestic positive case. 3 domestic confirmed cases recovered. There are currently 23 domestic confirmed cases in the city. Nangong District remains at High Risk.
Langfang did not report any new domestic positive cases. There are 1 domestic confirmed & 1 domestic asymptomatic cases there. The Medium Risk residential compound there was re-designated as Low Risk. ....

United States , United Kingdom , New York , Western Australia , Vyom Sharma , Anthony Fauci , Laurie Garrett , Tony Evers , Super Bowl , Associated Press , Kansas City Chiefs , Moscow Times , Use Approval , Republican Controlled Legislature , Peloton Infosec Analyst , Incident Response , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , புதியது யார்க் , மேற்கு ஆஸ்திரேலியா , வியோம் ஷர்மா , லாரி காரெட் , டோனி எவர்ஸ் , அருமை கிண்ணம் , தொடர்புடையது ப்ரெஸ் , கன்சாஸ் நகரம் முதல்வர்கள் ,

Corona Vaccination Drive: PM Narendra Modi Meeting With Chief Ministers, Read How States Are Preparing - कोरोना वैक्‍सीन लेटेस्‍ट न्‍यूज: किस राज्‍य को कैसे मिलेगी वैक्‍सीन, मुख्‍यमंत्रियों संग मीटिंग में पीएम मोदी ने बनाया ब्‍लूप्रिंट

Corona Vaccination Drive: PM Narendra Modi Meeting With Chief Ministers, Read How States Are Preparing - कोरोना वैक्‍सीन लेटेस्‍ट न्‍यूज: किस राज्‍य को कैसे मिलेगी वैक्‍सीन, मुख्‍यमंत्रियों संग मीटिंग में पीएम मोदी ने बनाया ब्‍लूप्रिंट
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Tamil Nadu , Satyendra Jan , Center On Workers , Delhia Health , It Center , India Biotech , Use Approval , Care Workers , Secretary Glory , Health Care Workers , Health Secretary Satyendra Jan , Frontline Workers , Training The , தமிழ் நாடு , அது மையம் , இந்தியா பயோடெக் , பயன்பாடு ஒப்புதல் , பராமரிப்பு தொழிலாளர்கள் , ஆரோக்கியம் பராமரிப்பு தொழிலாளர்கள் , முன்னணி தொழிலாளர்கள் , பயிற்சி தி ,

Some doctors say they would prefer Covishield jabs | India News


MUMBAI: The debate among medical professionals now is which one of the two vaccines granted emergency-use approval would they take, if given a choice.
Several doctors, including KEM Hospital dean Dr Hemant Deshmukh, said Covishield, developed by Oxford-AstraZeneca and manufactured by Serum Institute of India, would be their preferred vaccine since Covaxin’s efficacy data is not available yet. Incidentally, KEM was one of the sites where Covishield’s trial was conducted. “The reason is simple. We have to see Covaxin’s efficacy data and that trial is still on,” he explained.
Interestingly, Covishield’s complete immunogenicity (ability to generate an immune response) data on 1,600 Indian participants enrolled for the phase 2/3 trial too is not yet complete as data for only 400 has been evaluated. Dr Deshmukh, however, said there was the UK trial data to fall back on. ....

United Kingdom , Rahul Pandit , Krishna Ella , Randeep Guleria , Hemant Deshmukh , Serum Institute Of India , Serum Institute , National Expert Group , Vaccine Administration , Niti Aayog , Bharat Biotech , India News , India News Today , Today News , Google News , Breaking News , Use Approval , Oxford Astrazeneca , Kem Hospital , Efficacy Data , ஒன்றுபட்டது கிஂக்டம் , ராகுல் பண்டிட் , கிருஷ்ணா எல்லா , ரந்தீப் குலேரியா , ஹேமண்ட் தேஷ்முக்ஹ் , சீரம் நிறுவனம் ஆஃப் இந்தியா ,